PPIs may not promote infection, study finds

04/22/2013 | MedWire News (U.K.)

Patients taking a proton pump inhibitor had higher rates of Campylobacter and Salmonella infections than those not on the drugs, but data show they also were at higher risk for infection before beginning the medication, researchers reported in The American Journal of Gastroenterology. Researchers from Swansea University in the U.K. said infection risks increased over time for all patients. "Thus, increases in [gastrointestinal] infection after a PPI prescription are likely to be owing to a general increase in infection diagnosis rather than a result of the PPI prescription," according to the researchers.

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX